These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36831077)

  • 1. The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features.
    Miquel-Rio L; Sarriés-Serrano U; Pavia-Collado R; Meana JJ; Bortolozzi A
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
    Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
    Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy.
    Miquel-Rio L; Alarcón-Arís D; Torres-López M; Cóppola-Segovia V; Pavia-Collado R; Paz V; Ruiz-Bronchal E; Campa L; Casal C; Montefeltro A; Vila M; Artigas F; Revilla R; Bortolozzi A
    Transl Psychiatry; 2022 Feb; 12(1):79. PubMed ID: 35210396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Parkinson's Disease With the Alpha-Synuclein Protein.
    Gómez-Benito M; Granado N; García-Sanz P; Michel A; Dumoulin M; Moratalla R
    Front Pharmacol; 2020; 11():356. PubMed ID: 32390826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease.
    Tan Y; Sgobio C; Arzberger T; Machleid F; Tang Q; Findeis E; Tost J; Chakroun T; Gao P; Höllerhage M; Bötzel K; Herms J; Höglinger G; Koeglsperger T
    Acta Neuropathol; 2020 Feb; 139(2):319-345. PubMed ID: 31768670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.
    Yi S; Wang L; Wang H; Ho MS; Zhang S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of
    Magistrelli L; Contaldi E; Comi C
    Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson's Disease: Current Understanding and Knowledge Gaps.
    Huntington TE; Srinivasan R
    Aging Dis; 2021 Jul; 12(4):1120-1137. PubMed ID: 34221553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.
    Pavia-Collado R; Rodríguez-Aller R; Alarcón-Arís D; Miquel-Rio L; Ruiz-Bronchal E; Paz V; Campa L; Galofré M; Sgambato V; Bortolozzi A
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
    Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A
    Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease.
    Duperrier S; Bortolozzi A; Sgambato V
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease.
    Park SJ; Jin U; Park SM
    PLoS Pathog; 2021 Oct; 17(10):e1010018. PubMed ID: 34695168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse.
    Song LK; Ma KL; Yuan YH; Mu Z; Song XY; Niu F; Han N; Chen NH
    PLoS One; 2015; 10(6):e0131281. PubMed ID: 26114655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal haemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synuclein.
    Santulli C; Bon C; De Cecco E; Codrich M; Narkiewicz J; Parisse P; Perissinotto F; Santoro C; Persichetti F; Legname G; Espinoza S; Gustincich S
    Cell Death Dis; 2022 Dec; 13(12):1048. PubMed ID: 36526614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.